Business · 16/10/20261 min read
Sobi receives positive CHMP opinion for TRYNGOLZA® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)
Summary
Sobi has received a positive opinion from the CHMP for its treatment TRYNGOLZA® (olezarsen) for severe hypertriglyceridemia, based on Phase 3 CORE and CORE2 results.
Original source language: PR NewswireOpen original release →